SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 79 filers reported holding SERES THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $482,000 | -16.5% | 67,000 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $577,000 | +31.7% | 67,000 | +3.1% | 0.00% | 0.0% |
Q3 2021 | $438,000 | -71.3% | 65,000 | 0.0% | 0.00% | -75.0% |
Q2 2021 | $1,527,000 | +22.7% | 65,000 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $1,245,000 | +1224.5% | 65,000 | +99.4% | 0.00% | – |
Q2 2019 | $94,000 | -44.0% | 32,600 | +64.6% | 0.00% | -100.0% |
Q1 2019 | $168,000 | +124.0% | 19,800 | +21.5% | 0.00% | – |
Q4 2018 | $75,000 | -55.4% | 16,300 | -17.7% | 0.00% | -100.0% |
Q3 2018 | $168,000 | -7.7% | 19,800 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $182,000 | +23.8% | 19,800 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $147,000 | -46.4% | 19,800 | -2.5% | 0.00% | -50.0% |
Q4 2017 | $274,000 | 0.0% | 20,300 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $274,000 | +16.1% | 20,300 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $236,000 | -61.1% | 20,300 | 0.0% | 0.00% | -71.4% |
Q2 2016 | $606,000 | +43.6% | 20,300 | +20.8% | 0.01% | +40.0% |
Q1 2016 | $422,000 | – | 16,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |